Article
Elimination of highly multidrug-resistant wound bacteria by the lactic acid bacterial drug candidate ILP100
2024-12-19
Abstract excerpt
<title>Abstract</title> <p>The rise and spread of antibiotic resistance poses a global threat, further exacerbated by geopolitical conflicts. <italic>Limosilactobacillus reuteri</italic> genetically modified to produce human CXCL12 (ILP100) has previously been shown to accelerate wound healing. Here, we report that ILP100 has potent bactericidal effects against MDR wound pathogens isolated from Ukrainian war vict...
Topics
Open a Topic to create a Post that cites this publication.
- Antimicrobial Peptides and Activities
- Aquaculture disease management and microbiota
- Bacteriophages and microbial interactions
- Clostridium difficile and Clostridium perfringens research
- Infant Nutrition and Health
- Microbial Natural Products and Biosynthesis
- Probiotics and Fermented Foods
- Viral gastroenteritis research and epidemiology
Identifiers and source
- Literature Corpus work
- c91dfb12-cf80-5541-886e-9f43ca9b36c5
- DOI
- 10.21203/rs.3.rs-5587281/v1
